Indiana’s Senate Health and Provider Services Committee on Wednesday unanimously approved a bill that would fund clinical research trials into psilocybin, making two relatively minor amendments before advancing the legislation.
“There’s reason to believe that there is value in psilocybin and, at this point, I want to elevate the discussion,” said Sen. Ed Charbonneau (R), the bill’s sponsor and committee chair. “We need to be taking a look at something like this that is so important to our veterans with PTSD and many other issues.”
Charbonneau emphasized that the bill does not change the legal status of psilocybin under Indiana law. Instead it seeks to propel research into the substance, which the federal government has granted breakthrough-therapy status.
“I am in no way, and this bill in no way, seeks to legalize anything that isn’t legalized today,” he told colleagues. “The breakthrough therapy designation was given because there have been a number of well recognized studies that have been done already on psilocybin, and it’s mainstream research in places such as Johns Hopkins.”
Though Charbonneau initially indicated the panel wouldn’t take final action on his bill until next week, the committee ended up holding a vote during the last few
Read full article on Marijuana Moment
